Integra Lifesciences (NSDQ:IART) posted first-quarter results that beat the overall consensus on Wall Street. The Princeton, N.J.-based surgical and medical instrument company reported profits of $32.9 million, or 39¢ per share, on sales of $376.6 million for the three months ended March 31, for a bottom-line loss of 27.5% on sales growth of 4.6% compared […]
Integra LifeSciences
Integra Lifesciences beats The Street in Q4 results
Integra Lifesciences (NSDQ:IART) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Princeton, N.J.-based surgical and medical instrument company reported profits of $45.4 billion, or 53¢ per share, on sales of $405.5 million for the three months ended Dec. 31, 2021, for a sales growth of 4.34% compared with Q4 2020. […]
12 of medtech’s biggest personnel changes in 2021
As medtech companies continued to drive innovation throughout the past 12 months, a number of high-level executives led the way. Some of those companies and those executives opted for major changes over the course of 2021, though, with some high-profile moves from medtech giant to medtech giant. Here are some of the biggest personnel moves […]
Integra rises on Street-beating Q3, raised EPS guidance
Integra LifeSciences (NSDQ:IART) shares got a boost this morning on third-quarter results that topped the consensus forecast. IART shares were up 5.6% at $70.95 per share in early morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.2%. The Princeton, New Jersey-based surgical and […]
Integra Lifesciences announces new CEO
Integra LifeSciences (NSDQ:IART) announced today that former Barco CEO Jan D. De Witte will take over the corner office at Integra by the end of the year. De Witte left Barco effective September 1. He will succeed Peter J. Arduini, who is leaving Integra Lifesciences to lead GE Healthcare. The top spot at Integra will […]
Integra Lifesciences raises guidance on Street-beating Q2 results
Integra LifeSciences (NSDQ:IART) today posted second-quarter results that beat the overall consensus on Wall Street. The Princeton, N.J.–based surgical and medical instrument company reported profits of $35.1 million, to 41¢ per share, on sales of $389.9 million, for the three months ended June 30, for a sales growth of 50.8% compared with Q2 2020. Earnings per […]
MedTech 100 roundup: Nearing new highs once again
Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set […]
Integra Lifesciences CEO steps down to succeed GE Healthcare CEO Murphy
Integra LifeSciences (NSDQ:IART) announced today that Peter Arduini will step down as CEO to accept a new role leading GE Healthcare (NYSE:GE). Princeton, N.J.–based Integra said in a news release that Arduini will step down at the end of 2021 to become president & CEO at GE Healthcare. Current president and CEO of GE Healthcare, […]
Integra Lifesciences ticks up before hours on Street-beating Q1 results
Integra LifeSciences (NSDQ:IART) today posted first-quarter results that beat the consensus on Wall Street. The company reported profits of $45.4 million, or 53¢ per share, on sales of $360.1 million for the three months ended March 31, for a bottom-line gain of 394.5% on sales growth of 1.62% compared with Q1 2020. Adjusted to exclude one-time […]
The top 7 medtech CEO quotes on COVID-19, one year later
The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world […]
Integra LifeSciences posts earnings beat in Q4
Integra LifeSciences (NSDQ:IART) shares dipped today despite fourth-quarter results that beat the consensus earnings forecast. The Princeton, N.J.-based medtech company posted profits of $92.7 million, or $1.09 per share, on sales of $388.6 million for the three months ended Dec. 31, 2020, coming in well ahead of its Q4 2019 profit of $15.3 million despite a […]
